[6] Whether these combined effects meaningfully contribute to changes in skin physiology such as altered sensitivity or localised reactions remains speculative and has not been confirmed in published clinical trial data
You can also look for manufacturer copay cards and savings programs that make these drugs more affordable
Platforms like MeAgain provide structured injection-site logging, side-effect timelines, and smart reminders, giving people a single source of truth so patterns surface quickly and conversations with clinicians are faster and more precise
Limitations Not yet FDA-approved (as of 2025)
If you have Graves' disease, toxic nodules, or thyroiditis, your endocrinologist and primary care provider should review your GLP-1 plan collaboratively
The answer, based on the data, is yes